Envista Holdings Corp. (NVST)
27.02
-0.36
(-1.31%)
USD |
NYSE |
Apr 15, 16:00
27.02
0.00 (0.00%)
After-Hours: 20:00
Envista Holdings Research and Development Expense (Annual) : 114.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| Dentsply Sirona, Inc. | 150.00M |
| Solventum Corp. | 727.00M |